Promega, UW Screening Facility And NIH Chemical Genomics Center Bring Chemical Genomics Symposium To University Of Wisconsin-Madison

Main Category: Biology / Biochemistry
Article Date: 22 Jan 2009 - 7:00 PDT

email to a friend   printer friendly   view / write opinions   rate article

NIH Chemical Genomics Center, UW Small Molecule Screening Facility, and Promega Corporation Partner to Sponsor a Chemical Genomics Symposium at the University of Wisconsin-Madison, Feb 6th. The symposium will feature how small molecule screening is expanding from pharmaceutical drug discovery into academic research.

Jim Inglese, the Deputy Director of NIH (National Institutes of Health) Chemical Genomics Center, will headline the all day event. Speakers from Kansas University, the University of Minnesota, the University of Michigan and the University of Wisconsin will provide examples of how small molecules modulators can be used to understand signaling pathways important in normal and pathological cellular behavior.

High throughput screening of chemical libraries often provides the starting point for selection of the appropriate chemical scaffolds. However, academic labs often do not have the resources to implement ultra high throughput screens. This symposium will provide an understanding of how investigators can interact with local screening centers to facilitate success of a screening project, and the process involved in getting a screen selected for inclusion in an uHTS facility within the NIH Molecular Libraries Probe Production Centers Network.

The symposium will be held Friday, February 6, 2009, 9:00a.m.-5:00p.m., at the Ebling Symposium Center University of Wisconsin-Madison, Microbial Sciences Building, 1510 Linden Drive, Madison, WI. There is no charge for the symposium, lunch will be provided.

For more information, visit http://www.promega.com/uwsymposium.

Promega Corporation is a leader in providing innovative solutions and technical support to the life sciences industry. The company's 2,000 products enable scientists worldwide to advance their knowledge in genomics, proteomics, cellular analysis, molecular diagnostics and human identification. Founded in 1978, the company is headquartered in Madison, WI, USA with branches in 14 countries and over 50 global distributors.

http://www.promega.com